Press releases Image EN FR Proton Therapy / 18.08.2022 IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia Read more IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia
Press releases Image EN FR Proton Therapy / 02.08.2022 IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy Read more IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
Press releases Image EN FR Corporate / 11.07.2022 IBA Notice of Half Year 2022 Results and Conference Call Read more IBA Notice of Half Year 2022 Results and Conference Call
Press releases Image EN FR Proton Therapy / 30.06.2022 IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy Read more IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy
Press releases Image FR EN Proton Therapy / 30.06.2022 IBA launches the ConformalFLASH® Alliance Read more IBA launches the ConformalFLASH® Alliance
Press releases Image EN FR Proton Therapy / 01.06.2022 IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA Read more IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA
Legal Image EN FR CN DE PT IT RU ES Corporate / 31.05.2022 IBA Website Personal Data Policy Read more IBA Website Personal Data Policy
Press releases Image EN FR Corporate / 19.05.2022 IBA Business Update – First Quarter 2022 Read more IBA Business Update – First Quarter 2022
Press releases Image EN FR Dosimetry / 07.05.2022 IBA continues to shape the future of dosimetry at ESTRO 2022 Read more IBA continues to shape the future of dosimetry at ESTRO 2022
Press releases Image EN FR Proton Therapy / 06.05.2022 IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress Read more IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress
Press releases Image EN FR Proton Therapy / 05.05.2022 IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China Read more IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China
Press releases Image EN FR Dosimetry / 03.05.2022 IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc. Read more IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.
Press releases Image FR EN Corporate / 22.04.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Proton Therapy / 05.04.2022 IBA and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer Read more IBA and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer
Press releases Image EN FR Corporate / 24.03.2022 IBA Reports Full Year 2021 Results Read more IBA Reports Full Year 2021 Results
Press releases Image FR EN Proton Therapy / 15.03.2022 IBA and Tractebel announce partnership to support proton therapy construction projects Read more IBA and Tractebel announce partnership to support proton therapy construction projects
Press releases Image EN FR Corporate / 10.03.2022 IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM Read more IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM
Press releases Image EN FR Corporate / 08.03.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 08.03.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
